Pregnancy-induced hypertension (PIH), which includes both gestational hyper
tension and preeclampsia, is a common and morbid pregnancy complication for
which the pathogenesis remains unclear. Emerging evidence suggests that in
sulin resistance, which has been linked to essential hypertension, may play
a role in PIH. Conditions associated with increased insulin resistance, in
cluding gestational diabetes, polycystic ovary syndrome, and obesity, may p
redispose to hypertensive pregnancy. Furthermore, metabolic abnormalities l
inked to the insulin resistance syndrome are also observed in women with PI
H to a greater degree than in normotensive pregnant women: These include gl
ucose intolerance, hyperinsulinemia, hyperlipidemia, and high levels of pla
sminogen activator inhibitor-1, leptin, and tumor necrosis factor-alpha. Th
ese observations suggest the possibility that insulin resistance may be inv
olved in the pathogenesis of PIH and that approaches that improve insulin s
ensitivity might have benefit in the prevention or treatment of this syndro
me, although this requires further study.